Palvella Therapeutics, Inc.
PVLA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $694 | $249 | $62 | $27 |
| - Cash | $64 | $70 | $76 | $84 |
| + Debt | $0 | $15 | $0 | $0 |
| Enterprise Value | $630 | $193 | -$13 | -$57 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$8 | -$7 | -$4 |
| % Margin | – | – | – | – |
| Net Income | -$11 | -$9 | -$8 | -$4 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.03 | -0.86 | -3.68 | -0.88 |
| % Growth | -19.8% | 76.6% | -318.2% | – |
| Operating Cash Flow | $0 | -$5 | -$7 | -$5 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $0 | -$5 | -$7 | -$5 |